{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:02:37Z","timestamp":1787166157175,"version":"build-2736575974"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T00:00:00Z","timestamp":1638144000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T00:00:00Z","timestamp":1638144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["5\/7\/329\/2009-RHN"],"award-info":[{"award-number":["5\/7\/329\/2009-RHN"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Neonatal sepsis is a global public health problem. There is no consensus regarding the optimum duration of antibiotics for culture-proven neonatal sepsis. Published randomized controlled trials (RCTs) comparing shorter versus longer courses of antibiotics provide low-quality evidence with serious risk of bias. We hypothesized that among neonates with uncomplicated culture-proven sepsis, antibiotic duration of 7\u2009days is not inferior to 14\u2009days.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This is a multi-centric, parallel-group, stratified, block-randomized, active-controlled, non-inferiority trial with outcome assessment blinded. Stratification is by center and birth weight. Neonates weighing \u22651000 g at birth, with blood-culture-proven sepsis (barring\n                      <jats:italic>Staphylococcus aureus<\/jats:italic>\n                      and fungi), without conditions warranting &gt;\u200914\u2009days antibiotics, and who clinically remit, are enrolled in the RCT on day 7 of administration of sensitive antibiotics. They are randomly allocated to no further antibiotics (intervention arm: total 7\u2009days) or 7 more days of the same antibiotics (control arm: total 14\u2009days). Allocation is concealed by opaque, sealed envelopes. The primary outcome is \u201cdefinite or probable relapse\u201d within 21\u2009days after antibiotic completion. Secondary outcomes include definite and probable relapses at various timepoints until day 35 post-randomization, secondary infections, and adverse events. The neonatologist adjudicating probable relapses and lab personnel are blinded. Three hundred fifty subjects will be recruited in each arm, assuming a non-inferiority margin of 7%, one-sided alpha error 5%, and power of 90%. Analysis will be per protocol and by intention-to-treat. An independent Data Safety Monitoring Board monitors adverse events and will perform one interim analysis when 50% of expected primary outcomes have occurred or 50% of subjects have completed follow-up, whichever is earlier. O\u2019Brien-Fleming criteria will be used to stop for mid-term benefit and Pocock\u2019s to stop for mid-term harm. A priori subgroup analyses are planned by birth weight categories, gram-stain status of pathogens, and radiological pneumonia.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This trial will provide evidence to guide practice regarding optimum duration of antibiotics for culture-proven neonatal bacterial sepsis. If a 7-day regime is proved to be non-inferior to a 14-day regime, it is likely to reduce hospital stay, costs, adverse effects of drugs, and nosocomial infections.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      Clinical Trials Registry India\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/ctri.nic.in\">CTRI\/2017\/09\/009743<\/jats:ext-link>\n                      . Registered on 13 September 2017.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-021-05785-6","type":"journal-article","created":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T04:02:31Z","timestamp":1638158551000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Comparison of efficacy of a 7-day versus a 14-day course of intravenous antibiotics in the treatment of uncomplicated neonatal bacterial sepsis: study protocol of a randomized controlled non-inferiority trial"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5595-8289","authenticated-orcid":false,"given":"Sourabh","family":"Dutta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushma","family":"Nangia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamta","family":"Jajoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geeta","family":"Gathwala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saudamini","family":"Nesargi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mangalabharathi","family":"Sundaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvind","family":"Saili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipti","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poonam","family":"Dalal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. N.","family":"Suman Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramya","family":"Shanmugam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pallab","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valinderjeet Singh","family":"Randhawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karnika","family":"Saigal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhu","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savitha","family":"Nagaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devasena","family":"Radhakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,29]]},"reference":[{"issue":"9938","key":"5785_CR1","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0140-6736(14)60496-7","volume":"384","author":"JE Lawn","year":"2014","unstructured":"Lawn JE, Blencowe H, Oza S, You D, Lee AC, Waiswa P, et al. Every Newborn: progress, priorities, and potential beyond survival. Lancet. 2014;384(9938):189\u2013205. https:\/\/doi.org\/10.1016\/S0140-6736(14)60496-7.","journal-title":"Lancet."},{"key":"5785_CR2","doi-asserted-by":"publisher","first-page":"k5314","DOI":"10.1136\/bmj.k5314","volume":"364","author":"S Chaurasia","year":"2019","unstructured":"Chaurasia S, Sivanandan S, Agarwal R, Ellis S, Sharland M, Sankar MJ. Neonatal sepsis in South Asia: huge burden and spiralling antimicrobial resistance. BMJ. 2019;364:k5314. https:\/\/doi.org\/10.1136\/bmj.k5314.","journal-title":"BMJ."},{"issue":"8","key":"5785_CR3","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/jp.2017.67","volume":"37","author":"P Panigrahi","year":"2017","unstructured":"Panigrahi P, Chandel DS, Hansen NI, Sharma N, Kandefer S, Parida S, et al. Neonatal sepsis in rural India: timing, microbiology and antibiotic resistance in a population-based prospective study in the community setting. J Perinatol. 2017;37(8):911\u201321. https:\/\/doi.org\/10.1038\/jp.2017.67.","journal-title":"J Perinatol"},{"issue":"3","key":"5785_CR4","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S2213-2600(18)30063-8","volume":"6","author":"C Fleischmann-Struzek","year":"2018","unstructured":"Fleischmann-Struzek C, Goldfarb DM, Schlattmann P, Schlapbach LJ, Reinhart K, Kissoon N. The global burden of paediatric and neonatal sepsis: a systematic review. Lancet Respir Med. 2018;6(3):223\u201330. https:\/\/doi.org\/10.1016\/S2213-2600(18)30063-8.","journal-title":"Lancet Respir Med"},{"issue":"6","key":"5785_CR5","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1093\/tropej\/fml054","volume":"52","author":"G Chowdhary","year":"2006","unstructured":"Chowdhary G, Dutta S, Narang A. Randomized controlled trial of 7-Day vs. 14-Day antibiotics for neonatal sepsis. J Trop Pediatr. 2006;52(6):427\u201332. https:\/\/doi.org\/10.1093\/tropej\/fml054.","journal-title":"J Trop Pediatr"},{"issue":"6","key":"5785_CR6","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/tropej\/fmq012","volume":"56","author":"G Gathwala","year":"2010","unstructured":"Gathwala G, Sindwani A, Singh J, Choudhry O, Chaudhary U. Ten days vs. 14\u2009days antibiotic therapy in culture-proven neonatal sepsis. J Trop Pediatr. 2010;56(6):433\u20135. https:\/\/doi.org\/10.1093\/tropej\/fmq012.","journal-title":"J Trop Pediatr"},{"issue":"6","key":"5785_CR7","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1111\/jpc.13518","volume":"53","author":"S Rohatgi","year":"2017","unstructured":"Rohatgi S, Dewan P, Faridi MMA, Kumar A, Malhotra RK, Batra P. Seven versus 10\u2009days antibiotic therapy for culture-proven neonatal sepsis: a randomised controlled trial. J Paediatr Child Health. 2017;53(6):556\u201362. https:\/\/doi.org\/10.1111\/jpc.13518.","journal-title":"J Paediatr Child Health"},{"key":"5785_CR8","unstructured":"Neofax Essentials. 2014. http:\/\/ypeda.com\/attachments\/fil\/Micormedex%20NeoFax%20Essentials%202014%20(1).pdf. Accessed 15 March 2021."},{"key":"5785_CR9","unstructured":"The Central Drugs Standard Control Organisation (CDSCO), Government of India. https:\/\/cdsco.gov.in\/opencms\/opencms\/en\/Clinical-Trial\/SAE\/. Accessed 15 March 2021."},{"key":"5785_CR10","unstructured":"National Health Mission, Government of India. http:\/\/www.nrhmhp.gov.in\/content\/ reporting-formats-child-health. Accessed 15 March 2021."},{"key":"5785_CR11","unstructured":"Common Terminology Criteria for Adverse Events. https:\/\/evs.nci.nih.gov\/ftp1\/ CTCAE\/CTCAE_4.03\/CTCAE_4.03_2010-06-14_QuickReference_8.5 \u00d7 11.pdf. Accessed 15 March 2021."},{"key":"5785_CR12","unstructured":"World Health Organization-Uppsala Monitoring Centre causality assessment. https:\/\/www.who.int\/medicines\/areas\/quality_safety\/safety_efficacy\/WHOcausality_assessmeas.pdf. Accessed 15 March 2021."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-021-05785-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-021-05785-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-021-05785-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T04:04:00Z","timestamp":1638158640000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-021-05785-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,29]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["5785"],"URL":"https:\/\/doi.org\/10.1186\/s13063-021-05785-6","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,29]]},"assertion":[{"value":"25 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institute Ethics Committee approved the study protocol (PGI\/IEC\/2015\/1374). Written informed consent to participate will be obtained from the parents of all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"Consent for publication is not applicable. However, the informed consent form for participants enrolled in the study has been provided in the\n                      \n                      .","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"859"}}